Anzeige
Mehr »
Donnerstag, 16.10.2025 - Börsentäglich über 12.000 News
Jetzt folgt der nächste Coup - CiTech mit Lettland jetzt auf Europas Verteidigungsbühne
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
16.10.25 | 08:02
5,650 Euro
+1,80 % +0,100
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,6505,85010:48
5,6505,90009:57

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.09.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report4
23.09.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)142CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
04.09.Lifecore granted Sector Weight rating at KeyBanc on growth trajectory1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
19.08.Does LifeCore (LFCR) Have a High Expected Value?1
18.08.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
07.08.Lifecore Biomedical GAAP EPS of -$0.06 beats by $0.04, revenue of $36.4M beats by $1.04M1
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - S-8, Securities to be offered to employees in employee benefit plans1
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - 10-K, Annual Report1
07.08.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
07.08.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update150-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting...
► Artikel lesen
31.07.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 20251
18.07.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report2
17.07.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)105CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
18.06.Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy-
17.06.Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement with Existing Customer1
17.06.Lifecore Biomedical signs new 10-year commercial manufacturing and supply agreement2
17.06.Lifecore signs 10-year manufacturing deal with key ophthalmic client1
17.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer1
17.06.Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy1
12.06.Lifecore Receives Full Payment Early For $17 Mln Equipment Sale3
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1